Side-by-side comparison of AI visibility scores, market position, and capabilities
Bengaluru/Boston robotic digital pathology with RoboTome (2x sectioning speed) and MorphoLens (100+ slides/hour);
Morphle Labs is a Bengaluru, India and Boston, Massachusetts-based robotic microscopy and digital pathology company — raising $5 million in Series A funding in November 2025 led by Inflexor Ventures — providing histopathology laboratories with AI-powered physical automation platforms that address the speed and throughput bottlenecks in cancer diagnostics workflows. With 80+ patents filed and products deployed in leading US and European laboratories, Morphle's 100-member team has developed two flagship platforms: RoboTome (a robotic microtome system that slices biopsy tissue blocks at 2x the speed of experienced histotechnologists) and MorphoLens (a high-throughput slide scanner that digitizes 100+ histology slides per hour for digital pathology review). Founded to "revolutionize cancer diagnostics with physical AI," Morphle expands manufacturing, regulatory clearances, and global presence with the Series A.
Browser Use is an open-source Python library that enables AI agents to control web browsers, making it easy for LLMs to interact with any website through a clean, model-agnostic API.
Browser Use is an open-source project that provides a Python library allowing AI agents and large language models to control web browsers as a tool. The library sits between LLM APIs and browser automation frameworks like Playwright, providing a clean, model-agnostic interface that makes it straightforward for AI agents to navigate websites, fill forms, extract information, and complete multi-step web tasks without requiring developers to write custom browser control code.
Morphle Labs vs
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.